Spanish Ebola patient gets experimental drug
MADRID, Spain - Spain says it has imported a U.S.-made experimental drug to treat a Spanish missionary priest who was evacuated from Liberia last week after testing positive for Ebola.
A Health Ministry statement Monday said the ZMapp drug, made by Mapp Biopharmaceutical Inc. of San Diego, was obtained in Geneva this weekend and brought to Madrid to treat Miguel Pajares.
Two Americans diagnosed with Ebola in Liberia recently have been treated with the drug and are said to be improving.
There is no known cure for Ebola and more than 1,000 people have died in the current outbreak in West Africa.
Pajares, 75, was evacuated from Liberia and placed in isolation Thursday in Madrid's Carlos III hospital.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
Deal done: Louisiana session ends with deep cuts stopped
Girls State reaction at NSULA to TOPS promise
Dangerously hot weather not stopping locals from getting outside
LSU begins digitizing century-old editions of longtime campus newspaper
Hundreds of volunteers pick up litter around the capital city